Cristiano Ronaldo Takes 10% Stake in Herbalife's Pro2col Platform

ProA Capital Acquires 50% Stake in Patatas Hijolusa

December 21, 2021

Food & Beverage

Spanish private equity firm ProA Capital has acquired a 50% stake in Patatas Hijolusa in a transaction valued at about €100 million via a share purchase and a capital increase. The founding family (José and Carlos Gómez Pérez) will retain 50% and continue to run the business as Hijolusa pursues international expansion (France and Italy), increased R&D and digitalization, and a buy-and-build strategy.

Summa Equity Acquires Majority Stake in Nutris

September 3, 2024

Food & Beverage

Impact investor Summa Equity has acquired a majority stake in Nutris, a Croatian plant-based protein ingredients manufacturer founded in 2019. The investment will support scaling Nutris’s manufacturing capacity and R&D to expand production of fava-bean protein isolates and other plant-based ingredients for food, sports nutrition and dairy/meat alternative markets.

Houlihan Lokey Acquires Baylor Klein

July 8, 2021

Professional Services

Houlihan Lokey, Inc. (NYSE: HLI) has acquired boutique advisory firm Baylor Klein, bringing the firm's five-person M&A and corporate finance team into Houlihan Lokey's European Corporate Finance business in London. The acquisition expands Houlihan Lokey's Consumer, Food & Retail (CFR) coverage by adding specialist expertise in household, beauty, and personal care (HBPC) assets.

Italgel S.p.A. (BU portfolio company) Acquires Protein S.A.

February 13, 2024

Food & Beverage

Italgel S.p.A., a gelatine and collagen manufacturer backed by BU Bregal Unternehmerkapital, has acquired Protein S.A., a Spanish specialist in hydrolysed collagen. The acquisition is an add-on to strengthen Italgel's international market position and expand its range of collagen solutions across food, pharmaceutical and supplement end markets.

Montagu Acquires Majority Stake in HTL Biotechnology

February 28, 2022

Pharmaceuticals

Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.

Crown Aesthetics (Crown Laboratories) Acquires Select Assets from Healeon LLC (Bimini Health Tech)

July 23, 2024

Medical Devices

Crown Aesthetics, a Crown Laboratories company, has acquired select assets and technology from Healeon LLC, a subsidiary of Bimini Health Tech, to strengthen its ProGen PRP Eclipse platelet-rich plasma (PRP) offering. The asset purchase expands Crown's PRP device portfolio, supports new product development, and aims to extend Crown's geographic and production capabilities in the regenerative and aesthetic medicine markets.